4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001209191-15-005096
CIK 0001325879operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:32 PM ET
Size
5.4 KB
Accession
0001209191-15-005096
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Sale
Common Stock
2015-01-16$0.82/sh−3,075$2,512→ 14,506 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2014, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.801 to $0.84, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:32 PM ET
- Size
- 5.4 KB